Arcadia Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9M | Buy |
32,324
+54
| +0.2% | +$29.3K | 2.72% | 12 |
|
|
2025
Q4 | $18.7M | Sell |
32,270
-962
| -3% | -$544K | 3.03% | 10 |
|
|
2025
Q3 | $16.1M | Buy |
33,232
+1,030
| +3% | +$479K | 2.49% | 14 |
|
|
2025
Q2 | $13.1M | Buy |
32,202
+1,136
| +4% | +$475K | 2.09% | 17 |
|
|
2025
Q1 | $15.5M | Sell |
31,066
-1,205
| -4% | -$653K | 2.8% | 11 |
|
|
2024
Q4 | $16.8M | Buy |
32,271
+111
| +0.3% | +$61K | 2.68% | 11 |
|
|
2024
Q3 | $19.9M | Sell |
32,160
-594
| -2% | -$352K | 3.27% | 9 |
|
|
2024
Q2 | $18.1M | Sell |
32,754
-158
| -0.5% | -$90.5K | 3.09% | 8 |
|
|
2024
Q1 | $19.1M | Sell |
32,912
-29
| -0.1% | -$16.3K | 3.38% | 7 |
|
|
2023
Q4 | $17.5M | Sell |
32,941
-433
| -1% | -$210K | 3.34% | 8 |
|
|
2023
Q3 | $16.9M | Buy |
33,374
+500
| +2% | +$266K | 3.58% | 6 |
|
|
2023
Q2 | $17.2M | Buy |
32,874
+311
| +1% | +$168K | 3.48% | 6 |
|
|
2023
Q1 | $18.8M | Sell |
32,563
-826
| -2% | -$466K | 4.08% | 3 |
|
|
2022
Q4 | $18.4M | Buy |
33,389
+472
| +1% | +$250K | 4.29% | 2 |
|
|
2022
Q3 | $16.7M | Sell |
32,917
-1,295
| -4% | -$725K | 4.04% | 2 |
|
|
2022
Q2 | $18.6M | Sell |
34,212
-192
| -0.6% | -$106K | 4.15% | 1 |
|
|
2022
Q1 | $20.3M | Sell |
34,404
-843
| -2% | -$484K | 3.84% | 3 |
|
|
2021
Q4 | $23.5M | Sell |
35,247
-394
| -1% | -$246K | 3.93% | 2 |
|
|
2021
Q3 | $20.4M | Sell |
35,641
-725
| -2% | -$398K | 3.76% | 3 |
|
|
2021
Q2 | $18.3M | Sell |
36,366
-1,643
| -4% | -$775K | 3.45% | 3 |
|
|
2021
Q1 | $17.3M | Sell |
38,009
-1,385
| -4% | -$661K | 3.47% | 3 |
|
|
2020
Q4 | $18.3M | Sell |
39,394
-4,220
| -10% | -$1.98M | 3.79% | 3 |
|
|
2020
Q3 | $19.3M | Buy |
43,614
+1,610
| +4% | +$665K | 4.15% | 3 |
|
|
2020
Q2 | $15.2M | Sell |
42,004
-772
| -2% | -$259K | 3.71% | 3 |
|
|
2020
Q1 | $12.1M | Sell |
42,776
-28
| -0.1% | -$8.83K | 3.67% | 2 |
|
|
2019
Q4 | $13.9M | Buy |
42,804
+677
| +2% | +$205K | 3.52% | 3 |
|
|
2019
Q3 | $12.3M | Sell |
42,127
-1,119
| -3% | -$320K | 3.35% | 4 |
|
|
2019
Q2 | $12.7M | Buy |
43,246
+1,336
| +3% | +$368K | 3.46% | 2 |
|
|
2019
Q1 | $11.5M | Sell |
41,910
-528
| -1% | -$131K | 3.32% | 3 |
|
|
2018
Q4 | $9.5M | Sell |
42,438
-1,625
| -4% | -$381K | 3.18% | 3 |
|
|
2018
Q3 | $10.8M | Sell |
44,063
-223
| -0.5% | -$51.3K | 2.84% | 4 |
|
|
2018
Q2 | $9.17M | Sell |
44,286
-860
| -2% | -$183K | 2.56% | 5 |
|
|
2018
Q1 | $9.32M | Sell |
45,146
-1,509
| -3% | -$317K | 2.63% | 6 |
|
|
2017
Q4 | $8.86M | Buy |
46,655
+695
| +2% | +$133K | 2.48% | 7 |
|
|
2017
Q3 | $8.7M | Buy |
45,960
+3,497
| +8% | +$633K | 2.66% | 7 |
|
|
2017
Q2 | $7.41M | Buy |
42,463
+1,854
| +5% | +$311K | 2.35% | 7 |
|
|
2017
Q1 | $6.24M | Buy |
40,609
+2,126
| +6% | +$325K | 1.97% | 10 |
|
|
2016
Q4 | $5.43M | Buy |
38,483
+9,545
| +33% | +$1.41M | 1.78% | 13 |
|
|
2016
Q3 | $4.6M | Sell |
28,938
-1,120
| -4% | -$173K | 1.53% | 22 |
|
|
2016
Q2 | $4.44M | Buy |
30,058
+795
| +3% | +$117K | 1.45% | 25 |
|
|
2016
Q1 | $4.14M | Buy |
29,263
+4,240
| +17% | +$568K | 1.36% | 25 |
|
|
2015
Q4 | $3.55M | Buy |
25,023
+765
| +3% | +$102K | 1.08% | 36 |
|
|
2015
Q3 | $2.97M | Sell |
24,258
-778
| -3% | -$101K | 0.91% | 46 |
|
|
2015
Q2 | $3.25M | Buy |
25,036
+1,530
| +7% | +$199K | 0.84% | 46 |
|
|
2015
Q1 | $3.16M | Sell |
23,506
-1,031
| -4% | -$133K | 0.88% | 49 |
|
|
2014
Q4 | $3.07M | Sell |
24,537
-19,399
| -44% | -$2.36M | 0.87% | 47 |
|
|
2014
Q3 | $5.35M | Buy |
43,936
+8
| +0% | +$973 | 1.6% | 30 |
|
|
2014
Q2 | $5.18M | Sell |
43,928
-2,678
| -6% | -$315K | 1.51% | 30 |
|
|
2014
Q1 | $5.6M | Sell |
46,606
-12,055
| -21% | -$1.43M | 1.64% | 26 |
|
|
2013
Q4 | $6.53M | Sell |
58,661
-250
| -0.4% | -$24.9K | 1.55% | 24 |
|
|
2013
Q3 | $5.43M | Buy |
58,911
+970
| +2% | +$87.7K | 1.41% | 30 |
|
|
2013
Q2 | $4.9M | Buy |
+57,941
| New | +$4.82M | 1.39% | 25 |
|
Other funds holding TMO
VCM
Arcadia Investment Management's TMO Position: Q1 2026 in Review
Arcadia Investment Management increased its Thermo Fisher Scientific (TMO) stake by 0.17% in Q1 2026, buying an estimated $29.3K and bringing the position to 32,324 shares worth $15.9M. The position accounts for 2.72% of the portfolio, ranked #12.
Arcadia Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.5M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Arcadia Investment Management held 32,324 shares of Thermo Fisher Scientific worth $15.9M as of Q1 2026.
- Arcadia Investment Management bought 54 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3K.
- Thermo Fisher Scientific made up 2.72% of Arcadia Investment Management's portfolio in Q1 2026, its #12 holding.
- Arcadia Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Arcadia Investment Management's Thermo Fisher Scientific position peaked at $23.5M in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.